EMEA-000583-PIP01-09-M08

Key facts

Invented name
Victrelis
Active substance
Boceprevir
Therapeutic area
Infectious diseases
Decision number
P/0156/2020
PIP number
EMEA-000583-PIP01-09-M08
Pharmaceutical form(s)
  • Granules
  • Capsule, hard
Condition(s) / indication(s)
Treatment of chronic hepatitis C
Route(s) of administration
Oral use
Contact for public enquiries
Merck Sharp & Dohme (Europe) Inc.

Tel.: +33180464738
E-mail: pip.information@merck.com

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

Related content

How useful was this page?

Add your rating